JP2008013542A5 - - Google Patents

Download PDF

Info

Publication number
JP2008013542A5
JP2008013542A5 JP2007138744A JP2007138744A JP2008013542A5 JP 2008013542 A5 JP2008013542 A5 JP 2008013542A5 JP 2007138744 A JP2007138744 A JP 2007138744A JP 2007138744 A JP2007138744 A JP 2007138744A JP 2008013542 A5 JP2008013542 A5 JP 2008013542A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
bromhexine
ambroxol
loxoprofen
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007138744A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008013542A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2007138744A priority Critical patent/JP2008013542A/ja
Priority claimed from JP2007138744A external-priority patent/JP2008013542A/ja
Publication of JP2008013542A publication Critical patent/JP2008013542A/ja
Publication of JP2008013542A5 publication Critical patent/JP2008013542A5/ja
Pending legal-status Critical Current

Links

JP2007138744A 2006-06-07 2007-05-25 去痰又は気道杯細胞過形成抑制のための医薬組成物 Pending JP2008013542A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007138744A JP2008013542A (ja) 2006-06-07 2007-05-25 去痰又は気道杯細胞過形成抑制のための医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006158130 2006-06-07
JP2007138744A JP2008013542A (ja) 2006-06-07 2007-05-25 去痰又は気道杯細胞過形成抑制のための医薬組成物

Publications (2)

Publication Number Publication Date
JP2008013542A JP2008013542A (ja) 2008-01-24
JP2008013542A5 true JP2008013542A5 (es) 2010-06-24

Family

ID=39070910

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007138744A Pending JP2008013542A (ja) 2006-06-07 2007-05-25 去痰又は気道杯細胞過形成抑制のための医薬組成物

Country Status (1)

Country Link
JP (1) JP2008013542A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010168373A (ja) * 2008-12-25 2010-08-05 Kowa Co ロキソプロフェン含有医薬組成物
JP2010215611A (ja) * 2009-01-28 2010-09-30 Kowa Co ロキソプロフェン含有医薬製剤
JP5624367B2 (ja) * 2009-05-28 2014-11-12 興和株式会社 ロキソプロフェン含有医薬製剤
JP5798735B2 (ja) * 2009-10-30 2015-10-21 興和株式会社 ロキソプロフェン含有医薬組成物
JP5897804B2 (ja) * 2010-02-26 2016-03-30 興和株式会社 ロキソプロフェン含有の医薬組成物
JP2012106977A (ja) * 2010-05-31 2012-06-07 Kowa Co ロキソプロフェンを含有する医薬組成物
EA025640B1 (ru) * 2010-07-12 2017-01-30 Бёрингер Ингельхайм Интернациональ Гмбх Водная композиция, содержащая бромгексин
JP5999892B2 (ja) * 2010-12-16 2016-09-28 第一三共ヘルスケア株式会社 ロキソプロフェンナトリウムとブロムヘキシンを含有する固形製剤
JP6008857B2 (ja) * 2011-07-29 2016-10-19 興和株式会社 ロキソプロフェンを含有する医薬組成物
JP2016135745A (ja) * 2014-01-20 2016-07-28 興和株式会社 ロキソプロフェン含有去痰医薬組成物
JP6554168B2 (ja) * 2014-05-23 2019-07-31 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アンブロキソール塩酸塩を含む咳止めシロップ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001172175A (ja) * 1999-12-14 2001-06-26 Taisho Pharmaceut Co Ltd 風邪用組成物

Similar Documents

Publication Publication Date Title
JP2008013542A5 (es)
FIC20230040I1 (fi) Koostumus käsittäen: sedatsuridiinia tai tämän farmaseuttisesti hyväksyttävää suolaa; ja desitabiinia.
NO2018029I1 (no) Alogliptin i kombinasjon med metformin, hver eventuelt i form av et farmasøytisk akseptabelt salt derav
IL193702A (en) Pharmaceutical preparation containing human embryonic stem cells, methods of manufacture and use thereof
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
JP2007527914A5 (es)
NO20091501L (no) Farmasoytiske sammensetninger
EP1991218A4 (en) USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
IL190137A0 (en) Crystals of laquinimod sodium, and process for the manufacture thereof
DK2024352T3 (da) Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling
EP2207891A4 (en) MATERIALS AND METHODS FOR GENERATING TRANSCRIPTS COMPRISING MODIFIED NUCLEOTIDES
ECSP088904A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
ATE509906T1 (de) Mandelsäurehydrazide
ZA200800408B (en) Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof
CL2013002905A1 (es) Composición farmacéutica que comprende fimasartan, una sal, solvato o hidrato del mismo y amlodipina, un isómero, sal, solvato o hidrato del mismo; uso en el tratamiento de hipertensión y enfermedades cardiovasculares.
IL204126A (en) Derivatives of 1, 3 - dihydroisoindole, their preparation, use, drugs and kit containing them and intermediates
AP2007004146A0 (en) 5-Phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other disease
JP2008531710A5 (es)
CL2007000680A1 (es) Compuesto cristalino (5s)-5-[4(cloro-piridin-2-iloxi)-piperidin-1-sulfonilmetil]-5-metil-imidazolidin-2,4-diona, forma g; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento de epoc.
IL185729A0 (en) Crystallization inhibitor and its use in gelatin capsules
PL2168584T3 (pl) Kompozycja farmaceutyczna zawierająca kombinację triazolobenzodiazepiny i selektywnego inhibitora wychwytu zwrotnego serotoniny
JP2008536808A5 (es)
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
IL177750A0 (en) Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
ZA200802774B (en) Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake